# OLIGOMA (NCT04495309)

> Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04495309
- Phase: NA
- Status: COMPLETED
- Sponsor: University Hospital Schleswig-Holstein
- Conditions: Metastatic Breast Cancer
- Interventions: Metastases-directed Radiotherapy
- Enrollment: 87
- Primary outcome: First co-primary outcome measure is progression-free survival (PFS)
- Primary outcome: Second co-primary outcome measure is quality of life

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 18

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=oligoma-nct04495309

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04495309", "email": "<work email>"}; the inbox owner confirms by the emailed link.